4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Editor's Choice- Heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pre-treatment with unfractionated heparin is common in ST-segment elevation myocardial infarction (STEMI) protocols, but the effect on intracoronary thrombus burden is unknown. We studied the effect of heparin pre-treatment on intracoronary thrombus burden and Thrombolysis in Myocardial Infarction (TIMI) flow prior to percutaneous coronary intervention in patients with STEMI.

          Related collections

          Author and article information

          Journal
          Eur Heart J Acute Cardiovasc Care
          European heart journal. Acute cardiovascular care
          SAGE Publications
          2048-8734
          2048-8726
          Feb 2019
          : 8
          : 1
          Affiliations
          [1 ] 1 Department of Cardiology, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
          [2 ] 2 Department of Medical Sciences, Uppsala University, Sweden.
          [3 ] 3 Department of Cardiology, Faculty of Health, Örebro University, Sweden.
          Article
          10.1177/2048872617727723
          28862032
          56ba70f2-9fa1-4d8f-9321-a46fded7201e
          History

          Heparin,pre-treatment,STEMI
          Heparin, pre-treatment, STEMI

          Comments

          Comment on this article